Context Therapeutics Inc. Market Cap History

Market Cap: $53.5 Million

USD as of Aug 2, 2026

Company Profile $CNTX

Context Therapeutics Inc. Market Capitalization Over Time

Evolution of Context Therapeutics Inc. market cap history

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Yearly Market Cap Evolution

Date Market Cap YoY Change

Market capitalization is calculated from the opening stock price at the beginning of each year.

Company Description

Profile

Context Therapeutics Inc. is a biopharmaceutical company focused on advancing treatments for hormone-driven female cancers. Primarily, the company develops investigational therapies targeting estrogen receptors, aiming to innovate in areas of significant unmet medical need. Context Therapeutics operates within the life sciences and biotechnology sectors, engaging in research and development to combat cancers like breast and ovarian cancer. The company's approach involves optimizing therapeutic outcomes through cutting-edge research, clinical trials, and strategic collaborations. With a strong commitment to patient-centered care, Context Therapeutics impacts the healthcare industry by striving to provide more effective and personalized treatment options for female cancer patients. Established in an era of increased focus on women's health, Context Therapeutics plays a vital role in the continued evolution and enhancement of oncology treatment solutions in the financial market.

Stocks & Indexes

Context Therapeutics Inc. main stocks and indexes inclusions.

$CNTX
Russell 2000 Russell 3000

What is Market Capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.